The 2023 American Heart Association scientific statement on obesity pharmacotherapy noted: "GLP-1 receptor agonists represent a pharmacologic class with demonstrated cardiovascular benefit that extends beyond traditional risk factor modification, including improvements in inflammation, endothelial function, and atherogenic lipid profiles" 12
Growth hormone facilitates the breakdown of fat stores, leading to a reduction in body fat percentage
GLP-1 agonists: treating weight loss with diabetes medication GLP-1 medications like Wegovy and Saxenda can help reduce hunger and support lasting weight loss
Ive tried medication that was prescribed by Cleveland Clinic
Long-term response varies from patient to patient
With the patients nausea, vomiting, abdominal pain, and rectal bleeding, gastroenterology was consulted